Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 24

Trial Status

Completed4
Other1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

17 collaborators·59 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Stanford University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinSarcoma
Similarity Score20%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

SarcomaLymphoma, Non-Hodgkin
Similarity Score20%

Mitchell Cairo, MD

New York Medical College

Related
14 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinSarcoma
Similarity Score20%

Project Leader

Ono Pharmaceutical Co., Ltd.

Related
47 trials

Shared therapeutic areas:

Gastrointestinal Stromal TumorsLymphoma, Non-Hodgkin

Worked with same sponsors:

Bristol-Myers Squibb
Similarity Score20%

Michael E. Williams, MD

University of Virginia Health Systems

Related
1 trials

Shared therapeutic areas:

Lymphoma, Non-Hodgkin

Worked with same sponsors:

Applied Molecular Evolution
Collaborated on 1 trial
Similarity Score14%

Nam Dang, MD

Nevada Cancer Institute

Related
1 trials

Shared therapeutic areas:

Lymphoma, Non-Hodgkin

Worked with same sponsors:

Applied Molecular Evolution
Collaborated on 1 trial
Similarity Score14%

Gerald Rosen, MD

St. Vincent's Comprehensive Cancer Center

Related
1 trials

Shared therapeutic areas:

Sarcoma

Worked with same sponsors:

Eleison Pharmaceuticals LLC.Threshold Pharmaceuticals
Collaborated on 1 trial
Similarity Score14%

Brad Pohlman, MD

The Cleveland Clinic

Related
1 trials

Shared therapeutic areas:

Lymphoma, Non-Hodgkin

Worked with same sponsors:

Applied Molecular Evolution
Collaborated on 1 trial
Similarity Score14%

Ian Flinn, MD, PhD

SCRI Development Innovations, LLC

Related
3 trials

Shared therapeutic areas:

Lymphoma, Non-Hodgkin

Worked with same sponsors:

Applied Molecular EvolutionNovartis
Collaborated on 1 trial
Similarity Score14%

Stephanie A. Gregory, MD

Rush University Medical Center

Related
1 trials

Shared therapeutic areas:

Lymphoma, Non-Hodgkin

Worked with same sponsors:

Applied Molecular Evolution
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT04118166Phase 2PrincipalInvestigator

Ipilimumab + Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma
Completed
NCT00354926Phase 1PrincipalInvestigator

Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma
Completed
NCT00441467Phase 2PrincipalInvestigator

Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma
Completed
NCT00742963Phase 1/2PrincipalInvestigator

Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma
Completed
NCT02342600Phase 2PrincipalInvestigator

SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor)

Gastrointestinal Stromal Tumors
Withdrawn

All 5 trials loaded